Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

Prudential Jennison Health Sciences Fund

+ Add to Watchlist

PHLAX:US

49.58 USD 0.50 1.00%

As of 09:29:30 ET on 01/30/2015.

Snapshot for Prudential Jennison Health Sciences Fund (PHLAX)

Year To Date: +4.01% 3-Month: +11.36% 3-Year: +36.48% 52-Week Range: 33.95 - 50.63
1-Month: +4.01% 1-Year: +29.26% 5-Year: +29.24% Beta vs SPR: 0.94

Mutual Fund Chart for PHLAX

No chart data available.
  • PHLAX:US 49.58
  • 1M
  • 1Y
Interactive PHLAX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for PHLAX

Prudential Jennison Health Sciences Fund is an open-end fund incorporated in the USA. The Fund's objective is long-term capital appreciation. The Fund invests at least 80% of assets plus borrowings for investment purposes in securities of companies in the health sciences sector, such as pharmaceutical, biotechnology and healthcare service providers.

Inception Date: 06-30-1999 Telephone: 1-800-225-1852
Managers: DAVID CHAN / MICHAEL DEL BALSO
Web Site: www.prudentialfunds.com

Fundamentals for PHLAX

NAV (on 2015-01-30) 49.58
Assets (M) (on 2015-01-30) 3,181.92
Fund Leveraged N
Minimum Investment 2,500.00
Minimum Subsequent Investment 100.00

Dividends for PHLAX

Dividend Type Short Term Cap Gain
Dividend Frequency Semi-Anl
Last Dividend Net (on 2014-12-23) 1.84
Dividend Yield (ttm) 13.94

Fees & Expenses for PHLAX

Front Load 5.50
Back Load 1.00
Current Mgmt Fee 0.73
Redemption Fee 0.00
12b1 Fee 0.30
Expense Ratio 1.15

Top Fund Holdings for PHLAX

Filing Date: 11/30/2014
Name Position Value % of Total
BioMarin Pharmaceutical Inc 1,752,708 157,252,962 5.309%
Covidien PLC 1,531,653 154,696,953 5.222%
Alexion Pharmaceuticals Inc 662,876 129,194,532 4.362%
Incyte Corp 1,607,959 121,481,302 4.101%
Vertex Pharmaceuticals Inc 737,060 86,884,633 2.933%
Roche Holding AG 287,488 86,028,078 2.904%
Alnylam Pharmaceuticals Inc 787,111 79,144,011 2.672%
Actavis plc 286,448 77,515,693 2.617%
Pacira Pharmaceuticals Inc/DE 816,450 76,689,149 2.589%
Isis Pharmaceuticals Inc 1,444,868 74,829,714 2.526%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil